AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%
Market Cap$460.2B
LTM Operating Income
$10.0B
YoY Growth
+22.1%
3Y CAGR
+111.6%
5Y CAGR
+27.9%
Stock quality & Intrinsic value
7/10
60.2% overvalued

AstraZeneca PLC Operating Income

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Operating Income
$4,547.0M
$6,502.0M
$8,216.0M
$8,094.0M
$9,144.0M
$11.5B
$11.5B
$12.8B
$8,148.0M
$3,712.0M
$2,137.0M
$4,114.0M
$4,902.0M
$3,677.0M
$3,387.0M
$2,924.0M
$5,162.0M
$1,056.0M
$3,757.0M
$8,193.0M
AZN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AZN and see if it's the right time to invest.
Dive in

AstraZeneca PLC (AZN) Operating Income comparison analysis

Crunching data... Almost there!

AZN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AstraZeneca PLC's Operating Income?

As of today, AstraZeneca PLC's last 12-month Operating Income is $10.0B, based on the financial report for Dec 31, 2024 (Q4 2024).

2) What is AstraZeneca PLC's Operating Income growth rate?

Over the last year, AstraZeneca PLC's Operating Income growth was 22.1%. The average annual Operating Income growth rates for AstraZeneca PLC have been 20.8% over the past three years, 27.9% over the past five years.

3) Is AstraZeneca PLC's Operating Income growth rate Good?

Over the last year, AstraZeneca PLC's Operating Income growth was 22.1%, which is higher than industry growth of 0.0%. It indicates that AstraZeneca PLC's Operating Income growth is Good.

4) How does AstraZeneca PLC's Operating Income growth rate compare to its peers?

Over the last year, AstraZeneca PLC's Operating Income growth was 22.1%, which is lower than peer median growth of 24.3%. The list of peers includes JNJ, LLY, MRK, PFE, NVS, ABBV, BMY, SNY, GILD, AMGN etc.